Page last updated: 2024-10-26
enoxacin and Mycoses
enoxacin has been researched along with Mycoses in 1 studies
Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.
Mycoses: Diseases caused by FUNGI.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients with acute nonlymphocytic leukemia, oral enoxacin prevents gram-negative infections, delays the onset of fever, does not alter the incidence of gram-positive or proven deep fungal infections, and is well tolerated." | 2.67 | Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group. ( Bond, L; Cassileth, PA; Correa-Coronas, R; Paradiso, L; Talbot, GH, 1993) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Talbot, GH | 1 |
| Cassileth, PA | 1 |
| Paradiso, L | 1 |
| Correa-Coronas, R | 1 |
| Bond, L | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prevention of Irinotecan Induced Diarrhea by Probiotics: A Phase III Study[NCT02819960] | Phase 3 | 233 participants (Actual) | Interventional | 2016-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Trials
1 trial available for enoxacin and Mycoses
| Article | Year |
|---|---|
Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group.
Topics: Administration, Oral; Adult; Aged; Bacterial Infections; Double-Blind Method; Enoxacin; Female; Huma | 1993 |